Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00093561 · ClinicalTrials.gov registry record · Phase 1
Lycopene in Preventing Prostate Cancer in Healthy Participants
A Phase 1 study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00093561: Completed Phase 1 study, sponsored by University of Illinois at Chicago.
NCT00093561 is a Phase 1 study that has completed, run by University of Illinois at Chicago. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00093561, a Phase 1 study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development or recurrence of cancer. The dietary supplement lycopene may prevent the development of prostate cancer. PURPOSE: This phase I trial is studying the side effects and best dose of lycopene in preventing prostate cancer in healthy participants.
Interventions
- DIETARY_SUPPLEMENT lycopene
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-08 |
| Est. Completion | 2006-02 |
| Phase | Phase 1 |
What the finished NCT00093561 record still lists
NCT00093561 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which lycopene is the first listed.
NCT00093561 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00093561 about?
NCT00093561 is a clinical study titled "Lycopene in Preventing Prostate Cancer in Healthy Participants". RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development or recurrence of cancer. The dietary supplement lycopene may prevent the development of prostate cancer. PURPOSE: This phase I trial is studying the side effects and best dose of lycopene in preven...
What is the current status of trial NCT00093561?
This trial is currently completed. It is a Phase 1 study. The study started on 2004-08. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00093561?
The interventions under investigation include: lycopene (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00093561?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia